Science deserves a path forward
Your research could become a therapy.
Host your research on MondoTwin. We help you strengthen and position your science, connect it with the right development partners, and move it closer to the patients who need it most.
- No fees for researchers or institutions
- You remain the scientific expert
- We help with the next steps
Choose your way in
How would you like to move rare-disease science forward?
Your scientific co-host
You host the science. We help with everything around it.
A promising discovery does not become a therapy on scientific merit alone. It also needs the right strategy, structure, and partners.
MondoTwin helps prepare your research for the next part of its journey—while keeping your knowledge and scientific contribution at the centre.
Research assessment & positioning
Target product profile development
Regulatory & clinical strategy
IP and exclusivity analysis
Financial and development modelling
Partner outreach & licensing support
No fees for researchers or institutions.
How it works
From your research to the right next step.
Begin with what you have. We guide the journey from there.
Tell us about your research
Start with a simple, non-confidential overview of your science.
Complete the scientific profile
We guide you through the evidence and information needed.
Explore the opportunity together
Our technology and experts assess potential, gaps, and next steps.
Build the development case
We shape the regulatory, clinical, IP, financial, and partnering path.
Meet the right partners
Connect with pharma, foundations, investors, governments, and specialists.
Stay connected to the science
Continue as scientific expert, adviser, collaborator, or development partner.
No complete development package needed.
For development partners
Your next program may already exist.
MondoTwin works with pharma, biotech, foundations, investors, and public funders looking for clinical-stage rare-disease programs. We find them in the evidence, construct them to be licensable, and support the transaction.
Your research may be rare.
Its potential should not be invisible.
Somewhere, a patient may be waiting for the science you already have.